Consolidated Statements of Cash Flows $ in Thousands	12 Months Ended
	Oct. 31, 2025 USD ($)	Oct. 31, 2024 USD ($)	Oct. 31, 2023 USD ($)
Operating activities:
Net income (loss)	$ 3,146	$ 16,933	$ (575)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net loss on sale of Maryland properties		356	1,003
Depreciation	2,965	2,981	2,944
Amortization	549	647	612
Stock based compensation expense		1	11
Directors fees and related interest paid in stock units			26
Stock awards granted to directors	140	141	140
Loss on investment in tenancy-in-common	135	170	271
Deferred rents - straight line rent	100	118	100
Bad debt expense	107	116	16
Accreted interest on investment in U.S. Treasury securities	(800)	(801)	(353)
Changes in operating assets and liabilities:
Tenants' security accounts	(73)	(57)	(23)
Accounts receivable, prepaid expenses and other assets	59	(48)	152
Accounts payable, accrued expenses and deferred director compensation payable	21	(448)	(1,954)
Deferred revenue	121	54	311
Deferred interest on mortgage	(222)
Net cash provided by operating activities	6,248	20,163	2,681
Investing activities:
Cash outlays from sale of Maryland properties, net		(356)	(1,003)
Purchase of U.S. Treasury securities	(48,184)	(45,663)	(38,444)
Proceeds from maturities of U.S. Treasury securities	60,082	40,786	15,204
Capital improvements - existing properties	(759)	(1,242)	(1,290)
Deferred leasing costs	(51)	(89)	(170)
Distribution from investment in tenancy-in-common	455	455	390
Net cash provided by(used in) investing activities	11,543	(6,109)	(25,313)
Financing activities:
Repayment of mortgages	(7,349)	(9,308)	(26,538)
Proceeds from mortgage loan refinancings			25,500
Proceeds from exercise of stock options		38	1,263
Deferred financing costs	(176)	(206)	(481)
Dividends paid	(7,167)	(1,491)	(13,721)
Distributions to noncontrolling interests in subsidiaries	(794)	(2,220)	(3,535)
Net cash used in financing activities	(15,486)	(13,187)	(17,512)
Net increase (decrease) in cash, cash equivalents and restricted cash	2,305	867	(40,144)
Cash, cash equivalents and restricted cash, beginning of year	19,223	18,356	58,500
Cash, cash equivalents and restricted cash, end of year	21,528	19,223	18,356
Supplemental disclosure of cash flow data:
Interest paid	7,044	6,783	7,182
Investing activities:
Accrued capital expenditures, construction costs and pre-development costs	27	237	210
Financing activities:
Dividends declared but not paid	747	5,224	372
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
Cash and cash equivalents	17,926	14,914	13,217
Tenants' security accounts	833	913	962
Funds held in post-closing escrow			883
Mortgage escrows (included in prepaid expenses and other assets)	2,769	3,396	3,294
Total cash, cash equivalents and restricted cash	$ 21,528	$ 19,223	$ 18,356